FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Adam Cole

Research Profile

Chemicals & Drugs

Phenomena

Phosphorylation

Disorders

Genes & Molecular Sequences

Amino Acid Sequences

Living Beings

Concepts & Ideas

Physiology

Anatomy

Co-author Network

Publications

TOP 3
Ritchie Williamson; Lynn Bedford; David Howlett; David M A Mann; John Mayer; Bettina Platt; Florian Plattner; Calum Sutherland; Alessia Usardi; Lidy van Aalten; Adam R Cole
CRMP2 hyperphosphorylation is characteristic of Alzheimer's disease and not a feature common to other neurodegenerative diseases.
M P M Soutar; P Thornhill; Adam R Cole; Calum Sutherland
Increased CRMP2 phosphorylation is observed in Alzheimer's disease; does this tell us anything about disease development?
Adam R Cole; Marc P M Soutar; Makoto Rembutsu; Lidy van Aalten; C James Hastie; Hilary McLauchlan; Mark Peggie; Martin Balastik; Kun Ping Lu; Calum Sutherland
Relative resistance of Cdk5-phosphorylated CRMP2 to dephosphorylation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Adam Cole (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Ritchie Williamson; Lynn Bedford; David Howlett; David M A Mann; John Mayer; Bettina Platt; Florian Plattner; Calum Sutherland; Alessia Usardi; Lidy van Aalten; Adam R Cole
CRMP2 hyperphosphorylation is characteristic of Alzheimer's disease and not a feature common to other neurodegenerative diseases.
Journal of Alzheimer's disease : JAD 2011;27(3):615-25.
2009: M P M Soutar; P Thornhill; Adam R Cole; Calum Sutherland
Increased CRMP2 phosphorylation is observed in Alzheimer's disease; does this tell us anything about disease development?
Current Alzheimer research 2009;6(3):269-78.
2008: Adam R Cole; Marc P M Soutar; Makoto Rembutsu; Lidy van Aalten; C James Hastie; Hilary McLauchlan; Mark Peggie; Martin Balastik; Kun Ping Lu; Calum Sutherland
Relative resistance of Cdk5-phosphorylated CRMP2 to dephosphorylation.
The Journal of biological chemistry 2008;283(26):18227-37.
2008: Makoto Rembutsu; Marc P M Soutar; Lidy Van Aalten; Robert Gourlay; C James Hastie; Hilary McLauchlan; Nick A Morrice; Adam R Cole; Calum Sutherland
Novel procedure to investigate the effect of phosphorylation on protein complex formation in vitro and in cells.
Biochemistry 2008;47(7):2153-61.
2007: Adam R Cole; Wendy Noble; Lidy van Aalten; Florian Plattner; Rena Meimaridou; Dale Hogan; Margaret Taylor; John LaFrancois; Frank J Gunn-Moore; Alexei Verkhratsky; Salvatore Oddo; Frank M LaFerla; peter giese; Kelly T Dineley; karen duff; Jill C Richardson; Shi Du Yan; Diane P Hanger; Stuart M Allan; Calum Sutherland
Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer's disease progression.
Journal of neurochemistry 2007;103(3):1132-44.
2007: Adam R Cole; Arlene Astell; Charlotte Green; Calum Sutherland
Molecular connexions between dementia and diabetes.
Neuroscience and biobehavioral reviews 2007;31(7):1046-63.
2006: Adam R Cole; frederic causeret; Gokhan Yadirgi; C James Hastie; Hilary McLauchlan; Edward J McManus; Félix Hernández; Britta J Eickholt; Margareta Nikolic; Calum Sutherland
Distinct priming kinases contribute to differential regulation of collapsin response mediator proteins by glycogen synthase kinase-3 in vivo.
The Journal of biological chemistry 2006;281(24):16591-8.
2004: Adam R Cole; Axel Knebel; Nick A Morrice; Laura A Robertson; Andrew J Irving; Christopher N Connolly; Calum Sutherland
GSK-3 phosphorylation of the Alzheimer epitope within collapsin response mediator proteins regulates axon elongation in primary neurons.
The Journal of biological chemistry 2004;279(48):50176-80.